Can Tyrosine Kinase Inhibitors Revolutionize Colorectal Cancer Treatment?
Colorectal cancer poses a formidable global health challenge, being the third most prevalent cancer and a leading cause of cancer mortality. Breakthrough advancements in the use of tyrosine kinase inhibitors (TKIs) herald new possibilities for targeted therapy, disrupting cancer cell growth while preserving healthy tissue. Despite their promise, TKIs present unique challenges, including complex tumor […]
3 minute read